Delving into the Latest Updates on University of Colorado System with Synapse

The usual campus responses to identity-based discrimination (gender, race, ethnicity, and pregnancy, for example) fail in addressing less severe forms of identity-based discrimination by mimicking adversarial processes found in the criminal justice system, focusing on formal investigation processes to address alleged violations. We advance a model that repairs yellow-zone behavior (cultural breaches) and argue that higher education campuses must look beyond traditional compliance-only responses toward an adaptable resolution model (ARM) grounded in restorative and mediation practices. An ARM model can mitigate and reduce yellow-zone behavior (cultural breaches) and related institutional betrayal and addresses harmful power dynamics.

2021-01-01·Post-Traumatic Stress Disorder

PTSD: The Medications

作者: J. F. Pagel

At some point, all of the types of psychotropic medication have been used to treat PTSD. Evidence, however, supports the use of only two very different categories of medication in treating PTSD – SSRI/SNRI antidepressants (selegiline, paroxetine, and venlafaxine) and antihypertensives affecting the catecholamine system (prazosin and propranolol). Other agents having proven effectiveness in treating common comorbid diagnoses (e.g., insomnia and depression) are often useful in treating PTSD. But there is very little evidence indicating any effectiveness for many of the drugs and medications used historically, and are still being used, to treat patients with PTSD. Some of these agents have significant side effects (e.g., benzodiazepines can exacerbate the response to trauma, suppress natural capacities to cope with stress, and induce disinhibition). Many induce significant daytime sleepiness after use (e.g., antipsychotics, sedatives, sedating antidepressants, and anticonvulsants). Some such as the opiates and sedatives are toxic in overdose, especially when combined with ethanol. Others (e.g., cannabis and psychedelics) have received only minimal study due to their illegal status. In treating PTSD, the results obtained even in the most successful medication trials are far less impressive than those attained using non-drug psychological therapies as PE, IRT, and EMDR. The addition of one of these psychological therapies to the treatment regimens of PTSD patients treated only with medication is strongly recommended.

2021-01-01·Post-Traumatic Stress Disorder

The Origins of PTSD: Psychodynamic Trauma and the Human Stress Response

作者: J. F. Pagel

There exist two well-developed and sometimes conflicting theories as to the cause of PTSD. Working from Freud’s theories of psychodynamics, the psychological community describes the origin of PTSD and other psychiatric disorders as a maladaptive response to irreconcilable trauma with focus on the neurocognitive processes of emotion and feeling. This theoretical perspective lies behind the psychoactive medications used to treat PTSD, as well as giving justification for the cognitive behavioral therapies that have proven so useful in treating its symptoms. An alternative approach to PTSD has been developed by physiologists and physicians who have focused on the chemistry and neuroanatomy of the human stress response. Their focus has been on the neuroendocrine chemistry of stress and the neuroanatomic systems involved in the neuro-processing of fear. This approach has led to the use of medications such as antihypertensives that block catecholamines in treating both nightmares and PTSD. Despite a lack of evidence that might tie these two approaches together, neuroscientists and clinicians routinely attempt to conflate these two very different approaches to diagnosing and treating PTSD.

1

项与 University of Colorado System 相关的新闻（医药）

2022-10-19

·PRNewswire

New Rankings of US Research Institutions Reveal Economic Benefits to Host Regions

Heartland Forward releases new report tracking tech transfer; building on previous research to offer policy suggestions aimed at increasing regional economic outcome BENTONVILLE, Ark., Oct. 19, 2022 /PRNewswire/ -- Technology transfers – or outputs from research institutions that lead to innovation beyond the walls of academia – are essential fuel for the economic growth of state economies. Building on the insights offered in Research to Renewal: Advancing University Tech Transfer, published in May 2022 and released at the organization's flagship event, Heartland Summit, Heartland Forward's new report From Research to Renewal, Part 2: States Realizing the Potential of Research Institutions provides the first new benchmark comparison for public universities structured as part of a state system and also considers institutions (hospitals, private research institutes and federal labs) that do not grant degrees but are important sources of research and innovation that bolster state economies. By presenting data that is useful for improving technology transfer and increasing the impact of universities and research institutions on their states' economies, the report supports governors, state agencies and state legislatures – the ultimate guardians of economic development – in making informed decisions about the future. The rankings Top 10 State University Systems for Tech Transfer* University of California System State University System of Florida University of Texas System University System of Ohio University of North Carolina System University of Illinois System Arizona Board of Regents University of Massachusetts System University of Georgia System University of Colorado System Top 10 Research Institutions for Tech Transfer* Mayo Foundation Medical Education Research, Minn Boston Children's Hospital, Mass Wistar Institute, Penn U. of Texas Southwestern Medical Center, Texas Cedars Sinai Medical Center, Calif Massachusetts General Hospital, Mass Memorial Sloan Kettering Cancer Center, N.Y. Cleveland Clinic, Ohio Dana Farber Cancer Institute, Mass Brigham Women's Hospital, Mass Key recommendations To achieve better outcomes, Heartland Forward recommends: Renewing the promise of innovation-driven economic growth in the United States through investments in scientific and technological innovation. Working together to strategically invest and deploy resources as state government and university officials. Bolstering technology transfer out of regional university research-based centers of excellence. Encouraging reporting, accountability and greater participation in the Association of University Technology Managers (AUTM) survey by public institutions. Pooling invention disclosures and patents. Increasing technology transfer efficiency by adopting best practice in commercialization at technology licensing offices (TLOs). Using alumni foundation investments as venture capital. Media Contact: Blake Woolsey, (479) 957-6301, [email protected] SOURCE Heartland Forward

100 项与 University of Colorado System 相关的药物交易

登录后查看更多信息

100 项与 University of Colorado System 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年11月22日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

临床前

1

临床1期

其他

3

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

Soljar(University of Colorado System)	皮肤疾病更多	临床1期
KGYY-15 ( CD40 x CD40L )	1型糖尿病更多	临床前
Pegtibatinase ( CBS )	同型半胱氨酸尿症更多	无进展
Fructokinase-C Inhibitors(Colorado Research Partners)	果糖不耐受更多	无进展
MeDZQ (University of Colorado System)	肺癌更多	无进展